⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10704155 | 0.87 | CYP2C19 (0.33) | — | |
| SCHEMBL9768346 | 0.81 | — | — | |
| SCHEMBL7630363 | 0.77 | — | — | |
| SCHEMBL23294925 | 0.75 | EPHX1 (0.33) | — | |
| SCHEMBL153693 | 0.67 | — | — | |
| SCHEMBL6757053 | 0.65 | — | — | |
| SCHEMBL23494104 | 0.64 | — | — | |
| SCHEMBL28875041 | 0.58 | LDHA (0.33) | — | |
| SCHEMBL66157 | 0.58 | — | — | |
| SCHEMBL2523687 | 0.58 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 271 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6991804-B2 | Delivery systems for periadventitial delivery for treatment of restenosis and anastomotic intimal hyperplasia | EDWARDS LIFESCIENCES CORPORATION (US) | 2006-01-31 | — | — | US | claimed |
| US-20040202711-A1 | Delivery systems for periadventitial delivery for treatment of restenosis and anastomotic intimal hyperplasia | HELMUS MICHAEL N (US) | 2004-10-14 | — | — | US | claimed |
| EP-0826082-B1 | INTERNALLY-COATED POROUS WEBS WITH CONTROLLED POSITIONING OF MODIFIERS THEREIN | NEXTEC APPLICATIONS INC (US) | 2001-03-28 | — | — | EP | claimed |
| US-20220184181-A1 | METHODS OF OCULAR TREATMENT USING AN ENGINEERED DIMERIC FRAGMENT OF HEPATOCYTE GROWTH FACTOR | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2022-06-16 | — | — | US | disclosed |
| US-20220033453-A1 | HEPATOCYTE GROWTH FACTOR FRAGMENTS THAT FUNCTION AS POTENT MET RECEPTOR AGONISTS AND ANTAGONISTS | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2022-02-03 | — | — | US | disclosed |
| US-20220023385-A1 | ENGINEERED FIBROBLAST GROWTH FACTOR VARIANTS COMBINED WITH ENGINEERED HEPATOCYTE GROWTH FACTOR VARIANTS FOR TREATMENT | THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS | 2022-01-27 | — | — | US | disclosed |
| EP-3863660-A2 | ENGINEERED FIBROBLAST GROWTH FACTOR VARIANTS AS RECEPTOR ANTAGONISTS | The Board of Trustees of the Leland Stanford Junior University (US) | 2021-08-18 | — | — | EP | disclosed |
| EP-3863715-A1 | ENGINEERED FIBROBLAST GROWTH FACTOR VARIANTS COMBINED WITH ENGINEERED HEPATOCYTE GROWTH FACTOR VARIANTS FOR TREATMENT | The Board of Trustees of the Leland Stanford Junior University (US) | 2021-08-18 | — | — | EP | disclosed |
| US-20210100876-A1 | Method of Treating of Fibroblast Growth Factor 21 (FGF-21) Deficiency | 89BIO, INC. | 2021-04-08 | — | — | US | disclosed |
| US-10874714-B2 | Method of treating fibroblast growth factor 21 (FGF-21) deficiency | 89BIO LTD. (IL) | 2020-12-29 | — | — | US | disclosed |
| WO-2018018010-A1 | FGF MUTANTS AND USES THEREOF | METACRINE, INC. (US) | 2018-01-25 | — | — | WO | disclosed |
| US-6083602-A | SHEDDING SHIELD BARRIER WEB TREATED WITH CURABLE, SHEAR, THINNED, THIXOTROPIC POLYMER; WATERPROOF, DURABLE | NEXTEC APPLICATIONS, INC. (US) | 2000-07-04 | — | — | US | disclosed |
| EP-0826083-B1 | BARRIER WEBS | NEXTEC APPLICATIONS INC (US) | 2000-04-05 | — | — | EP | disclosed |
| US-6040251-A | Garments of barrier webs | NEXTEC APPLICATIONS INC. (US) | 2000-03-21 | — | — | US | disclosed |
| US-5912116-A | BARRIER WEB OF CURABLE SHEAR THINNED THIXOTROPIC POLYMER | NEXTEC APPLICATIONS, INC. (US) | 1999-06-15 | — | — | US | disclosed |
| US-5874164-A | BIOACTIVE SUBSTRATE COMPRISING SUPPORT WITH SURFACE COMPRISING PARTIALLY CURED SHEAR THINNABLE THIXOTROPIC POLYMER CONTAINING BIOACTIVE MATERIAL ORIENTED OUTWARD FROM SURFACE | NEXTEC APPLICATIONS, INC. (US) | 1999-02-23 | — | — | US | disclosed |
| US-5869172-A | POROUS WEB TREATED WITH PARTIALLY CURED SHEAR THINNABLE THIXOTROPIC POLYMER AND MODIFIERS SELECTIVELY POSITIONED WITHIN WEB | NEXTEC APPLICATIONS, INC. (US) | 1999-02-09 | — | — | US | disclosed |
| US-5856245-A | MEDICAL | NEXTEC APPLICATIONS, INC. (US) | 1999-01-05 | — | — | US | disclosed |
| EP-0826082-A2 | INTERNALLY-COATED POROUS WEBS WITH CONTROLLED POSITIONING OF MODIFIERS THEREIN | Nextec Applications, Inc. (US) | 1998-03-04 | — | — | EP | disclosed |
| WO-1996036758-A2 | INTERNALLY-COATED POROUS WEBS WITH CONTROLLED POSITIONING OF MODIFIERS THEREIN | NEXTEC APPLICATIONS, INC. (US) | 1996-11-21 | — | — | WO | disclosed |